HSCS heartsciences.com: Prakiraan wutah bathi kanggo taun ngarep

HSCS (heartsciences.com) - tandha merek perusahaan

Heart Test Laboratories is implementing the MyoVista AI system for the rapid diagnosis of heart pathologies without the need for expensive ultrasound. The forward net income trend reflects market expectations, where the current figure stands at 28.70. Equipment reliability is ensured via careful air freight, while expansion into the primary care clinic segment allows the company to effectively bypass the saturation of the traditional electrocardiograph market.

HSCS: Prakiraan wutah bathi resik saben saham ing taun ngarep Heart Test Laboratories, Inc. 28.04.2023 - 10.11.2026

heartsciences.com - rincian analitis lan metrik utama (HSCS)

Pambiji fundamental:Heart Test Laboratories Inc.
Barang utama Heart Test Laboratories, Inc.

Investors are seeking confirmation of the business model's viability within Heart Test Laboratories (HSCS) financial reports through the dynamics of expected net earnings per share. Analyzing the earnings per share growth model for the coming year, experts are assessing the probability of overcoming operating losses and the adoption rate of AI cardiology in clinics, where any upward revision in forecasts signals market confidence in the commercialization of technologies despite competition from ECGs.

Analisis pesaing Heart Test Laboratories

Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS (exactsciences.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (Revvity)|Bio-Rad Laboratories, Inc. (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Tech - Prakiraan wutah bathi kanggo taun ngarep|SHC - Prakiraan wutah bathi kanggo taun ngarep|QuidelOrtho (QDEL) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|opko.com - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep CDNA|MRVI (Maravai LifeSciences Holdings) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep FLGT (Fulgent Corp)|LAB (Standard BioTools Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Cytek Biosciences, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep OSUR (orasure.com)|Exagen Diagnostics - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep MDxHealth S.A.|Lucid Diagnostics Inc (LUCD) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|PRE - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep IMDX|TRIB (Trinity Biotech Corp) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep PRPH (ProPhase Labs)|AIMD (Ainos Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Co-Diagnostics Corp CODX|Biomerica Inc - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Cardio Diagnostics Holdings, Inc. - Prakiraan wutah bathi kanggo taun ngarep|ONCO - Prakiraan wutah bathi kanggo taun ngarep|VRAX: Prakiraan wutah bathi kanggo taun ngarep|BJDX (Bluejay Diagnostics Inc) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vermillion|Prakiraan wutah bathi resik saben saham ing taun ngarep Accelerate Diagnostics Inc AXDX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Centogene NV (CNTG)|ENZ (enzo.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FRES (Fresh2 Group)|Prakiraan wutah bathi kanggo taun ngarep Genetic Technologies Ltd GENE|ME: Prakiraan wutah bathi saben saham kanggo taun ngarep|Psychemedics Inc - Proyeksi tambahing bathi saben saham ing taun ngarep